
INSP Stock Forecast & Price Target
INSP Analyst Ratings
Bulls say
Inspire Medical Systems is a promising medical technology company with a strong focus on the development and commercialization of their innovative Inspire system, a neurostimulation technology for the treatment of obstructive sleep apnea (OSA). The company has a solid presence in the US and international markets and is looking to expand further. Despite recent challenges in the coding and reimbursement landscape, the company's efforts to mitigate these uncertainties and the launch of their next-gen Inspire V device could drive a return to growth in 2027. With a strong product pipeline and potential for increased adoption, INSP is a Buy for long-term investors.
Bears say
Inspire Medical Systems is facing numerous obstacles that impact its fundamental outlook. The company's recent attempts to secure a new code for HGNS have been unsuccessful, and its current coding and reimbursement situation is uncertain. Additionally, the company has cut its revenue and EPS guidance for 2026, and there are potential risks to its market share and profitability from competition and alternative OSA treatment modalities. All of these factors contribute to a negative outlook on the company's stock.
This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.
INSP Analyst Forecast & Price Prediction
Start investing in INSP
Order type
Buy in
Order amount
Est. shares
0 shares